Your browser doesn't support javascript.
loading
Alpha-PET for Prostate Cancer: Preclinical investigation using 149Tb-PSMA-617.
Umbricht, Christoph A; Köster, Ulli; Bernhardt, Peter; Gracheva, Nadezda; Johnston, Karl; Schibli, Roger; van der Meulen, Nicholas P; Müller, Cristina.
Affiliation
  • Umbricht CA; Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, 5232, Villigen-PSI, Switzerland.
  • Köster U; Institut Laue-Langevin, 38042, Grenoble, France.
  • Bernhardt P; Department of Radiation Physics, Institution of Clinical Science, Sahlgrenska Academy, University of Gothenburg, 413 45, Gothenburg, Sweden.
  • Gracheva N; Medical Bioengeneering, Sahlgrenska University Hospital, 413 45, Gothenburg, Sweden.
  • Johnston K; Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, 5232, Villigen-PSI, Switzerland.
  • Schibli R; CERN, 1211, Geneva 23, Switzerland.
  • van der Meulen NP; Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, 5232, Villigen-PSI, Switzerland.
  • Müller C; Department of Chemistry and Applied Biosciences, ETH Zurich, 8093, Zurich, Switzerland.
Sci Rep ; 9(1): 17800, 2019 11 28.
Article in En | MEDLINE | ID: mdl-31780798
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms / Radioisotopes / Terbium / Dipeptides / Positron Emission Tomography Computed Tomography / Heterocyclic Compounds, 1-Ring Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Year: 2019 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms / Radioisotopes / Terbium / Dipeptides / Positron Emission Tomography Computed Tomography / Heterocyclic Compounds, 1-Ring Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Year: 2019 Type: Article